Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2012. Start Trial.
Date Value
October 14, 2026 488.29
October 13, 2026 472.59
October 12, 2026 484.23
October 09, 2026 476.22
October 08, 2026 469.24
October 07, 2026 467.42
October 06, 2026 459.37
October 05, 2026 457.77
October 02, 2026 452.71
October 01, 2026 447.73
September 30, 2026 450.59
September 29, 2026 453.52
September 28, 2026 458.67
September 25, 2026 455.33
September 24, 2026 456.67
September 23, 2026 456.60
September 22, 2026 456.82
September 21, 2026 455.57
September 18, 2026 454.67
September 17, 2026 454.77
September 16, 2026 452.17
September 15, 2026 453.09
September 14, 2026 450.90
September 11, 2026 442.89
September 10, 2026 439.24
Date Value
September 09, 2026 432.19
September 08, 2026 428.52
September 04, 2026 441.75
September 03, 2026 448.21
September 02, 2026 450.81
September 01, 2026 447.83
August 31, 2026 441.68
August 28, 2026 440.06
August 27, 2026 444.66
August 26, 2026 452.85
August 25, 2026 457.82
August 24, 2026 455.64
August 21, 2026 456.39
August 20, 2026 451.00
August 19, 2026 458.13
August 18, 2026 445.99
August 17, 2026 431.19
August 14, 2026 429.70
August 13, 2026 432.04
August 12, 2026 428.49
August 11, 2026 430.78
August 10, 2026 427.13
August 07, 2026 423.80
August 06, 2026 420.07
August 05, 2026 424.08

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Biogen, Inc. 232.83
Gilead Sciences, Inc. 225.03
Amgen, Inc. 638.07
REGENXBIO, Inc. 6.88
Abbott Laboratories 230.85